Acupuncture Effect on the Rate of Maturation in Post Term Pregnancies. (MATUPUNCTURE)

September 21, 2021 updated by: Centre Hospitalier Sud Francilien

Brief Summary Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis. (Limit: 5000 characters)

Example: The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive hearing loss in both ears due to autoimmune inner ear disease (AIED). The first purpose of this randomized study is to determine if five points of acupuncture : 4GI, 6RP, 34VB, 36E, 3F could improve the bishop score for prolonged pregnancies and decrease the rate of maturation.

The protocol of our study consists of proposing to the pregnant women one or two acupuncture sessions the term's day and three days later. Once the consent is signed, women are randomly included in the experimental or placebo arm. In the experimental arm, midwives puncture five points : 4GI, 6 RP, 34VB, 36E, 3F on each side while in the placebo arm, they puncture just one point : 16 HM on each side.

The maturation's rate between the two groups will be compared by a Fisher's exact test and analyzed in function parity (nulliparous or multiparous) and number of sessions (one or two) with a model of univariate and multivariate logistic regression.

Study Overview

Detailed Description

In maternity hospital center Corbeil-Essonnes, pregnant women have two monitoring consultations at term and three days later if they don't deliver between the two. At 41 weeks of amenorrhea and five days, women are convened in maternity for induction labour. Midwife determined Bishop's score with a vaginal exam to choose between a cervix's maturation (if bishop's score <5) or an induction of labour by oxytocin (if bishop's score>5).

The protocol of study consists of proposing to the pregnant women one or two acupuncture sessions the term's day and three days later. Once the consent is signed, women are randomly included in the experimental or placebo arm. In the experimental arm, midwives puncture five points : 4GI, 6 RP, 34VB, 36E, 3F on each side while in the placebo arm, they puncture just one point : 16 HM on each side.

At each consultation, the midwife collects the bishop's score to compare the average of it between the two arms and evaluate the rate of maturation.

The maturation's rate between the two groups will be compared by a Fisher's exact test and analyzed in function parity (nulliparous or multiparous) and number of sessions (one or two) with a model of univariate and multivariate logistic regression.

Finally, the average duration of induction labour will analyze, duration of labour and delivery route between the two arms.

Study Type

Interventional

Enrollment (Actual)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Corbeil-essonnes Cedex, France, 91106
        • Centre Hospitalier Sud Francilien

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Nulliparous or multipares with physiological pregnancy at 41 weeks
  • Cephalic foetal presentation,
  • Healthy or unicicatricial uterus,
  • Major patientes,
  • Speaking french,
  • Term of the pregnancy determinated with a dating ultrasound between 11 weeks and 13 weeks+ 6 days,
  • Having signed the form of consent participation.

Exclusion Criteria:

  • Foetal or maternal diseases requiring a maturation before 41 weeks : pre eclampsia, pre-existing diabetes, imbalance gestational diabetes, threat premature delivery treat with tocolytic, macrosomia or intrauterine growth retardation,
  • Diseases discoveries at 41 weeks : pre eclampsia, moves of the baby decrease, low amniotic fluid,anomalies of the foetal heartbeat
  • Circled pregnancy,
  • Twins or more,
  • Foetal death in utero, medical termination of pregnancy,
  • Unstuck membranes,
  • Minor patients
  • Patients who benefited acupuncture during pregnancy ,
  • Imprecise term of delivery,
  • Podalic presentation
  • Patients under supervision or curatorship,
  • Patients without social security.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acupuncture
In the experimental arm, pregnant women at term will benefit one or two acupuncture sessions with five points : 4GI, 6RP, 34VB,36E,3F. The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.
Puncture of 5 points 4GI, 6RP, 34VB, 36E, 3F
Placebo Comparator: Placebo acupuncture

In the placebo arm, pregnant women will benefit one or two acupuncture sessions with one point which is located outside the acupuncture meridian.

The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.

Puncture of point HM

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bishop score
Time Frame: At 41 weeks of amenorrhea
cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required (The highest possible score is 13 and the lowest possible score is 0)
At 41 weeks of amenorrhea
Bishop score
Time Frame: 3 days after the term of pregnancy
cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required
3 days after the term of pregnancy
Bishop score
Time Frame: 5 days after the term of pregnancy
cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required
5 days after the term of pregnancy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate spontaneous labour
Time Frame: At 41 weeks 5 days of amenorrhea
comparison of spontaneous labour's number in the two groups between 41 weeks of amenorrhea and 41 weeks of amenorrhea and five days.
At 41 weeks 5 days of amenorrhea
Duration labor
Time Frame: At 41 weeks 5 days of amenorrhea
comparison of average number of hours between entry into the delivery room and the delivery, in the two groups.
At 41 weeks 5 days of amenorrhea
Rate of delivery with medical intervention
Time Frame: At 41 weeks 5 days of amenorrhea
comparison medical intervention's number in the two groups.
At 41 weeks 5 days of amenorrhea
Rate of delivery by cesarean
Time Frame: At 41 weeks 5 days of amenorrhea
comparison cesarean's number in the two groups
At 41 weeks 5 days of amenorrhea

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 9, 2021

Primary Completion (Actual)

September 16, 2021

Study Completion (Actual)

September 16, 2021

Study Registration Dates

First Submitted

January 22, 2021

First Submitted That Met QC Criteria

February 4, 2021

First Posted (Actual)

February 8, 2021

Study Record Updates

Last Update Posted (Actual)

September 22, 2021

Last Update Submitted That Met QC Criteria

September 21, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IDRCB 2020-A03023-36

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Beyond 41 Week's Gestation

Clinical Trials on Acupuncture

3
Subscribe